Nurix Therapeutics (NRIX) Retained Earnings (2019 - 2026)
Nurix Therapeutics (NRIX) reported Retained Earnings of $56000.0 for Q1 2026, up 100.01% year-over-year from $27999.0 in Q1 2025, and down 46.67% quarter-over-quarter from $105000.0 in Q4 2025.
Nurix Therapeutics (NRIX) Retained Earnings (2019 - 2026) Analysis & Trends
Nurix Therapeutics (NRIX) has 8 years of Retained Earnings data on file, last reported at $56000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at $56000.0, up 100.01% year-over-year; the trailing twelve-month figure through Feb 2026 was $56000.0 (up 100.01% YoY), and the FY2025 annual result was $105000.0, up 100.01% from the prior year.
- Retained Earnings eased to $56000.0 in Q1 2026 per NRIX's latest filing, from $105000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $344000.0 in Q3 2024 and troughed at -$838.6 million in Q2 2025.
- A 5-year average of -$269.6 million and a median of -$4.3 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 1029520.0% in 2022, then soared 128.01% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$4.3 million in 2022, then surged by 84.83% to -$655000.0 in 2023, then tumbled by 112689.16% to -$738.8 million in 2024, then soared by 100.01% to $105000.0 in 2025, then slumped by 46.67% to $56000.0 in 2026.
- Business Quant data shows NRIX's Retained Earnings at $56000.0 in Q1 2026, $105000.0 in Q4 2025, and $119000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Nurix Therapeutics | 1.93 Bn | 1.39 Bn | - | 56,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 56,000.00 |
| Nov 30, 2025 | 105,000.00 |
| Aug 31, 2025 | 119,000.00 |
| May 31, 2025 | -838.58 Mn |
| Feb 28, 2025 | -795.10 Mn |
| Nov 30, 2024 | -738.77 Mn |
| Aug 31, 2024 | 344,000.00 |
| May 31, 2024 | -631.26 Mn |
| Feb 29, 2024 | -350,000.00 |
| Nov 30, 2023 | -655,000.00 |
| Aug 31, 2023 | -1.23 Mn |
| May 31, 2023 | -466.26 Mn |
| Feb 28, 2023 | -442.00 Mn |
| Nov 30, 2022 | -4.32 Mn |
| Aug 31, 2022 | -354.54 Mn |
| May 31, 2022 | -308.83 Mn |
| Feb 28, 2022 | -2.07 Mn |
| Nov 30, 2021 | -220.89 Mn |
| Aug 31, 2021 | -59,000.00 |
| May 31, 2021 | 30,000.00 |